|
Report Date : |
22.01.2014 |
IDENTIFICATION DETAILS
|
Name : |
BAYER
MATERIALSCIENCE LTD. |
|
|
|
|
Formerly Known as: |
Bayer Polymers Co.
Ltd. |
|
|
|
|
Registered Office : |
43/F., Hopewell Center, 183 Queen’s Road East, Wanchai |
|
|
|
|
Country : |
Hong Kong |
|
|
|
|
Date of Incorporation : |
11.02.1998 |
|
|
|
|
Com. Reg. No.: |
21927744 |
|
|
|
|
Legal Form : |
Private Limited Company |
|
|
|
|
Line of Business : |
Trader of Pharmaceutical and Medicine,
Veterinary Medicine, Pharmaceutical Preparation, Chemicals (including
Plastic Materials), Plastic Materials (including Resins and Sheet), Textile
Chemicals, Dyeing, Tanning and Colouring Materials, Industrial Chemicals,
Household Chemicals, Insecticide, Agro-Chemicals & Pesticide For
Agricultural Use |
|
|
|
|
No. of Employees : |
Company
Employees: 180. (Hong Kong) - Including associates Group Employees:
(As at 30-09-2013) 113,300. (Whole Group) 14,400. (Bayer MaterialScience Subgroup) |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30, 2013
|
Country Name |
Previous Rating (30.06.2013) |
Current Rating (30.09.2013) |
|
Hong Kong |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Hong Kong ECONOMIC OVERVIEW
Hong Kong has a free market economy, highly dependent on international trade and finance - the value of goods and services trade, including the sizable share of re-exports, is about four times GDP. Hong Kong levies excise duties on only four commodities, namely: hard alcohol, tobacco, hydrocarbon oil, and methyl alcohol. There are no quotas or dumping laws. Hong Kong's open economy left it exposed to the global economic slowdown that began in 2008. Although increasing integration with China, through trade, tourism, and financial links, helped it to make an initial recovery more quickly than many observers anticipated, it again faces a possible slowdown as exports to the Euro zone and US slump. The Hong Kong government is promoting the Special Administrative Region (SAR) as the site for Chinese renminbi (RMB) internationalization. Hong Kong residents are allowed to establish RMB-denominated savings accounts; RMB-denominated corporate and Chinese government bonds have been issued in Hong Kong; and RMB trade settlement is allowed. The territory far exceeded the RMB conversion quota set by Beijing for trade settlements in 2010 due to the growth of earnings from exports to the mainland. RMB deposits grew to roughly 9.1% of total system deposits in Hong Kong by the end of 2012, an increase of 59% from the previous year. The government is pursuing efforts to introduce additional use of RMB in Hong Kong financial markets and is seeking to expand the RMB quota. The mainland has long been Hong Kong's largest trading partner, accounting for about half of Hong Kong's exports by value. Hong Kong's natural resources are limited, and food and raw materials must be imported. As a result of China's easing of travel restrictions, the number of mainland tourists to the territory has surged from 4.5 million in 2001 to 34.9 million in 2012, outnumbering visitors from all other countries combined. Hong Kong has also established itself as the premier stock market for Chinese firms seeking to list abroad. In 2012 mainland Chinese companies constituted about 46.6% of the firms listed on the Hong Kong Stock Exchange and accounted for about 57.4% of the Exchange's market capitalization. During the past decade, as Hong Kong's manufacturing industry moved to the mainland, its service industry has grown rapidly. Growth slowed to 5% in 2011, and less than 2% in 2012. Credit expansion and tight housing supply conditions caused Hong Kong property prices to rise rapidly and inflation to rise 4.1% in 2012. Lower and middle income segments of the population are increasingly unable to afford adequate housing. Hong Kong continues to link its currency closely to the US dollar, maintaining an arrangement established in 1983.
|
Source : CIA |
BAYER MATERIALSCIENCE LTD.
43/F., Hopewell Center, 183 Queen’s Road East, Wanchai, Hong Kong.
PHONE: 852-2895 5888, 2158 2467
FAX: 852-3526 4505, 3526 4730, 2576 8862
E-MAIL: dirk.lang@bayermaterialscience.com
Managing Director: Mr. Johannes Matthias Dietsch
Incorporated on: 11th February, 1998.
Organization: Private Limited Company.
Capital: Nominal: HK$100,000.00
Issued: HK$100,000.00
Business Category: Plastic Material Trader.
Group Turnover: (Year ended 31-12-2012)
€39,760 million (Whole Group)
€11,503 million (Bayer MaterialScience Subgroup)
Company Employees: 180. (Hong Kong) - Including associates
Group Employees:- (As at 30-09-2013)
113,300. (Whole Group)
14,400. (Bayer MaterialScience Subgroup)
Main Dealing Banker: Deutsche Bank AG, Hong Kong Branch.
Banking Relation: Good.
Registered Head
Office:-
43/F., Hopewell Center, 183 Queen’s Road East, Wanchai, Hong Kong.
Holding Company:-
Bayer Far East Service Co. Ltd., Hong Kong.
Intermediate
Holding Company:-
Bayer MaterialScience AG, Germany.
Ultimate Holding
Company:-
Bayer AG, Germany.
Associated/Affiliated
Companies:-
Bayer Group of Companies
· Agreva GmbH, Germany.
AgrEvo
Verwaltungsgesellschaft mbH, Germany.
Alcafleu
Management GmbH & Co. KG, Germany.
Alimtec
S.A., Chile.
Artificial
Muscle Inc., USA.
Ausbildungsinitiative
Rheinland GmbH, Germany.
Baulé
Inc., US.
Baulé
S.A.S., France.
Baule
UK Ltd., UK.
Baulé
USA LLC, USA.
Bayer
(China) Ltd., China.
Bayer
(Malaysia) Sdn. Bhd., Malaysia.
Bayer
(Proprietary) Ltd., South Africa.
Bayer
(Schweiz) AG, Switzerland.
Bayer
(Sichuan) Animal Health Co. Ltd., China.
Bayer
(South East Asia) Pte Ltd., Singapore.
Bayer
04 Immobilien GmbH, Germany.
Bayer
04 Leverkusen Fußball GmbH, Germany.
Bayer
04 Leverkusen Sportförderung gGmbH, Germany.
Bayer
04 Marketing GmbH, Germany.
Bayer
A/S, Denmark.
Bayer
AB, Sweden.
Bayer
AEH Ltd., UK.
Bayer
AGCO Ltd., UK.
Bayer
Agriculture Ltd., UK.
Bayer
Algerie S.P.A., Algeria.
Bayer
Altersversorgung GmbH, Germany.
Bayer
Animal Health GmbH, Germany.
Bayer
Antwerpen NV, Belgium.
Bayer
AS, Norway.
Bayer
Australia Ltd., Australia.
Bayer
Austria Gesellschaft m.b.H., Austria.
Bayer
B.V., Netherlands.
Bayer
Beteiligungsverwaltung Goslar GmbH, Germany.
Bayer
BioScience Pvt. Ltd., India.
Bayer
Bitterfeld GmbH, Germany.
Bayer
Boliviana Ltda., Bolivia.
Bayer
Bulgaria EOOD, Bulgaria.
Bayer
Business and Technology Services LLC, USA.
Bayer
Business Services GmbH, Germany.
Bayer
Business Services Philippines Inc., Philippines.
Bayer
Business Services Private Ltd., India.
Bayer
Canadian Holdings Inc., Canada.
Bayer
Capital Corporation B.V., Netherlands.
Bayer
Chemicals AG, Germany.
Bayer
Co. (Malaysia) Sdn. Bhd., Malaysia.
Bayer
Consumer Care AG, Switzerland.
Bayer
Corporation, USA.
Bayer
Cotton Seed International Inc., USA.
Bayer
CropScience (China) Co. Ltd., China.
Bayer
CropScience (Portugal) Produtos para a Agricultura Lda., Portugal.
Bayer
CropScience AG, Germany.
Bayer
CropScience Beteiligungsgesellschaft mbH, Germany.
Bayer
CropScience Deutschland GmbH, Germany.
Bayer
CropScience Holding Inc., USA.
Bayer
CropScience Holding SA, France.
Bayer
CropScience Holdings Inc., Canada.
Bayer
CropScience Holdings Ltd., UK.
Bayer
CropScience Holdings Pty Ltd., Australia.
Bayer
CropScience Inc., Canada.
Bayer
CropScience Inc., Philippines.
Bayer
CropScience Inc., USA.
Bayer
CropScience K.K., Japan.
Bayer
CropScience LLC, USA.
Bayer
CropScience LP, USA.
Bayer
CropScience Ltd., Bangladesh.
Bayer
CropScience Ltd., India.
Bayer
CropScience Ltd., South Korea.
Bayer
CropScience Ltd., UK.
Bayer
CropScience N.V., Belgium.
Bayer
CropScience Norwich Ltd., UK.
Bayer
CropScience Pty Ltd., Australia.
Bayer
CropScience Raps GmbH, Germany.
Bayer
CropScience S.L., Spain.
Bayer
CropScience S.r.l., Italy.
Bayer
CropScience Vermögensverwaltungs-gesellschaft mbH, Germany.
Bayer
d.o.o. Sarajevo, Bosnia & Herzegovina.
Bayer
d.o.o., Croatia.
Bayer
d.o.o., Serbia.
Bayer
d.o.o., Slovenia.
Bayer
de Mexico S.A. de C.V., Mexico.
Bayer
Direct Services GmbH, Germany.
Bayer
East Africa Ltd., Kenya.
Bayer
Far East Service Co. Ltd., China.
Bayer
Finance & Portfolio Management S.A., Chile.
Bayer
Finance Ltda., Chile.
Bayer
Gastronomie GmbH, Germany.
Bayer
Gesellschaft für Beteiligungen mbH, Germany.
Bayer
Global Investments B.V., Netherlands.
Bayer
HealthCare AG, Germany.
Bayer
HealthCare Co. Ltd., China.
Bayer
HealthCare LLC, USA.
Bayer
HealthCare Ltd., China.
Bayer
HealthCare Manufacturing S.r.l., Italy.
Bayer
HealthCare Pharmaceuticals Inc., USA.
Bayer
HealthCare Pharmaceuticals LLC, USA.
Bayer
Healthcare S.r.l., Italy.
Bayer
Hellas AG, Greece.
Bayer
Hispania S.L., Spain.
Bayer
Holding France SCS, France.
Bayer
Holding Ltd., Japan.
Bayer
Hungaria Kft., Hungary.
Bayer
IMSA S.A. de C.V., Mexico.
Bayer
Inc., Canada.
Bayer
Innovation GmbH, Germany.
Bayer
Intellectual Property GmbH, Germany.
Bayer
International S.A., Switzerland.
Bayer
International Trade Services Corporation, USA.
Bayer
Israel Ltd., Israel.
Bayer
Jinling Polyurethane Co. Ltd., China.
Bayer
Korea Ltd., South Korea.
Bayer
Ltd., Ireland.
Bayer
Ltd., Ukraine.
Bayer
MaterialScience (Beijing) Co. Ltd., China.
Bayer
MaterialScience (China) Co. Ltd., China.
Bayer
MaterialScience (Qingdao) Co. Ltd., China.
Bayer
MaterialScience (Shanghai) Management Co. Ltd., China.
Bayer
MaterialScience A/S., Denmark.
Bayer
Materialscience Brunsbüttel Energie GmbH, Germany.
Bayer
MaterialScience Customer Services GmbH, Germany.
Bayer
MaterialScience GmbH, Germany.
Bayer
MaterialScience LLC, USA.
Bayer
MaterialScience Ltd., China.
Bayer
MaterialScience Ltd., Japan.
Bayer
MaterialScience Ltd., South Korea.
Bayer
MaterialScience N.V., Belgium.
Bayer
MaterialScience Oldenburg GmbH & Co. KG, Germany.
Bayer
MaterialScience Oldenburg Verwaltungs-GmbH, Germany.
Bayer
MaterialScience Private Ltd., India.
Bayer
MaterialScience Pty. Ltd., Australia.
Bayer
MaterialScience S.L., Spain.
Bayer
MaterialScience S.p.A., Italy.
Bayer
MaterialScience S.r.l., Italy.
Bayer
MaterialScience s.r.o., Czech Republic.
Bayer
MaterialScience Taiwan Ltd., Taiwan.
Bayer
MeterialScience B.V., Netherlands.
Bayer
Middle East FZE, UAE.
Bayer
New Zealand Ltd., New Zealand.
Bayer
Nordic SE, Finland.
Bayer
NV., Belgium.
Bayer
OÜ, Estonia.
Bayer
Overseas Trade Services Corporation, USA.
Bayer
Oy, Finland.
Bayer
Pakistan (Private) Ltd., Pakistan.
Bayer
Pearl Polyurethane Systems FZCO, UAE.
Bayer
Pearl Polyurethane Systems LLC., UAE.
Bayer
Pharma AG, Germany.
Bayer
Pharma Chemicals Inc., USA.
Bayer
Pharmaceuticals Private Ltd., India.
Bayer
Philippines Inc., Philippines.
Bayer
Polyols S.N.C., France.
Bayer
Polyurethanes B.V., Netherlands.
Bayer
Polyurethanes Taiwan Ltd., Taiwan.
Bayer
Portugal S.A., Portugal.
Bayer
Public Ltd. Co., UK.
Bayer
Puerto Rico Inc., Puerto Rico.
Bayer
Real Estate GmbH, Germany.
Bayer
Real Estate Leverkusen Verwaltungs-GmbH, Germany.
Bayer
Real Estate Waltersdorf Verwaltungs-GmbH, Germany.
Bayer
S.A. de C.V., Honduras.
Bayer
S.A., Argentina.
Bayer
S.A., Brazil.
Bayer
S.A., Chile.
Bayer
S.A., Colombia.
Bayer
S.A., Costa Rica.
Bayer
S.A., Dominican Republic.
Bayer
S.A., Ecuador.
Bayer
S.A., EI Salvador.
Bayer
S.A., Guatemala.
Bayer
S.A., Morocco.
Bayer
S.A., Nicaragua.
Bayer
S.A., Panama.
Bayer
S.A., Paraguay.
Bayer
S.A., Peru.
Bayer
S.A., Uruguay.
Bayer
S.A., Venezuela.
Bayer
S.A.R.L., France.
Bayer
S.A.S., France.
Bayer
S.p.A., Italy.
Bayer
s.r.o., Czech Republic.
Bayer
Santé Familiale SAS, France.
Bayer
Santé SAS, France.
Bayer
Schering Pharma AG, Germany.
Bayer
Sp. z.o.o., Poland.
Bayer
spol. s.r.o., Slovakia.
Bayer
Taiwan Co. Ltd., Taiwan.
Bayer
Technology and Engineering (Shanghai) Co. Ltd., China.
Bayer
Technology Services GmbH, Germany.
Bayer
Thai Co. Ltd., Thailand.
Bayer
TPU (Shenzhen) Co. Ltd., China.
Bayer
Türk Kimya Sanayi Ltd. Sirketi, Turkey.
Bayer
UK Ltd., UK.
Bayer
Uretech Ltd., Taiwan.
Bayer
US IP GmbH, Germany.
Bayer
Verwaltungsgesellschaft mbH, Germany.
Bayer
Vietnam Ltd., Vietnam.
Bayer
Vital GmbH, Germany.
Bayer
Weimar GmbH und Co. AG, Germany.
Bayer
West Coast Corporation, US.
Bayer
World Investments B.V., Netherlands.
Bayer
Yakuhin Ltd., Japan.
Bayer
Zydus Pharma Private Ltd., India.
Bayer-Handelsgesellschaft
mit beschränkter Haftung, Germany.
Bayer-Unterstützungskasse
GmbH, Germany.
Bayhealth
Comercializacãa de Produtos Garmacêuticos Unipessoal Lda., Portugal.
Bayhealth
S.L., Spain.
Baypo
I LLC, USA.
Baypo
II LLC, USA.
BAYPO
Ltd. Partnership, USA.
Baysalud
S.L., Spain.
Berlex
- Especialidades Farmacêuticas Lda., Portugal.
Berlex
Canada Inc., Canada.
Berlimed
- Especialidades Farmacêuticas Lda., Portugal.
Berlimed
S.A., Spain.
Berlipharm
B.V., Netherlands.
Berlis
AG, Swizerland.
BHCP
Holdings LLC, US.
Bilag
Industries Private Ltd., India.
Biogenetic
Technologies B.V., Netherlands.
BIPPO
Corporation, USA.
CENTROFARMA-Indústria
e Comério de Prod. Farmacêuticas Lda., Portugal.
Chemie-Beteiligungsaktiengesellschaft,
Switerland.
Chemion
Logistik GmbH, Germany.
CleanTech
NRW GmbH, Germany.
Codena
Inc., Canada.
Collateral
Therapeutics Inc., USA.
Cooper
Land Co. of New Jersey Inc., USA.
Corporación
Bonima S.A. de C.V., El Salvador.
Currenta
Geschäftsführungs-GmbH, Germany.
Currenta
GmbH & Co. OHG, Germany.
Delinting
& Seed Treating Co., US.
DIC
Bayer Polymer Ltd., Japan.
Dritte
Bayer Real Estate VV GmbH & Co. KG, Germany.
Drugofa
GmbH, Germany.
Dynevo
GmbH, Germany.
Ehrfeld
Mikrotechnik BTS GmbH, Germany.
Epurex
Films Geschäftsführungs-GmbH, Germany.
Epurex
Films GmbH & Co. KG, Germany.
Erste
Bayer Real Estate VV GmbH & Co. KG, Germany.
Erste
K-W-A Beteiligungsgesellschaft mbH, Germany.
Euroservices
Bayer GmbH, Germany.
Euroservices
Bayer S.L., Spain.
Fünfte
Bayer Real Estate VV GmbH & Co. KG, Germany.
Generics
Holding GmbH, Germany.
Goiania
Investimentos e Participacões Ltda, Brazil.
GP
Grenzach Produktions GmbH, Germany.
Guangzhou
Bayer MaterialScience Co. Ltd., China.
Guidance
Interactive Healthcare Inc., USA.
Hild
Samen GmbH, Germany.
Hornbeck
Seed Co. Inc., USA.
Imaxeon
Pty. Ltd., Australia.
Indurisk
Rückversicherung KG, Luxembourg.
Intendis
Derma S.L., Spain.
Intendis
GmbH, Germany.
Intendis
Inc., USA.
Intendis
llac Ticaret Ltd. Sirketi, Turkey.
Intendis
Manufacturing S.p.A., Italy.
Intraserv
GmbH & Go. KG, Germany.
Intraserv
Verwaltungs-GmbH, Germany.
iSense
Corporation, USA.
iSense
Development Corporation, USA.
Jenapharm
GmbH & Co. AG, Germany.
KOSINUS
Geschäftsführungs-Verwaltungsgesellschaft mbH, Germany.
KOSINUS
Grundstücks-Verwaltungsgesellschaft mbH & Co. Gamma OHG, Germany.
KVP
Pharma+Veterinär Produkte GmbH, Germany.
Lilienthalstraße
Nr. 4 GmbH, Germany.
Lusal
Producão Quimico Farmacêutica Luso-Alema Lda., Portugal.
Lusalfarma
- Especialidadees Farmacêutica Lda.,
Portugal.
Lyondell
Bayer Manufacturing Maasvlakte VOF, Netherlands.
Marotrast
GmbH, Germany.
Medipharm
(Pvt) Ltd., Pakistan.
Mediterranean
Seeds Ltd., Israel.
Mediwest
Norway AS, Norway.
Medrad
Asia Pte. Ltd., Singapore.
Medrad
Belgium BVBA, Belgium.
Medrad
Denmark ApS, Denmark.
Medrad
do Brasil Ltda., Brazil.
Medrad
Europe B.V., Netherlands.
Medrad
France S.A.R.L., France.
Medrad
Inc., USA.
Medrad
Italia S.r.l., Italy.
Medrad
Medical Equipment Trading Co., China.
Medrad
Medizinische Systeme GmbH, Germany.
Medrad
Mexicana S. de R.L. de CV, Mexico.
Medrad
Sweden AB, Sweden.
Medrad
UK Ltd., UK.
MENADIER
Heilmittel GmbH, Germany.
Neunte
Bayer VV GmbH, Germany.
Nihon
Medrad K.K., Japan.
NippoNex
Holdings LLC, US.
NippoNex
Inc., USA.
NOR-AM
Agro LLC, USA.
NOR-AM
Land Co., USA.
Nunhems
B.V., Netherlands.
Nunhems
Beijing Seeds Co. Ltd., China.
Nunhems
Chile S.A., Chile.
Nunhems
do Brasil Comercio de Sementes Ltds., Brazil.
Nunhems
France S.A.R.L., France.
Nunhems
Hungary Kft., Hungary.
Nunhems
India Private Ltd., India.
Nunhems
Italy S.r.l., Italy.
Nunhems
Melons Inc., USA.
Nunhems
Mexico S.A. de C.V., Mexico.
Nunhems
Netherlands B.V., Netherlands.
Nunhems
Poland Sp. z.o.o., Poland.
Nunhems
Spain S.A., Spain.
Nunhems
Tohumculuk Ltd. Sirketi, Turkey.
Nunhems
USA Inc., USA.
Pallas
Versicherung AG, Germany.
Paltough
Industries (1998) Ltd., Israel.
Pandias
Re AG, Luxembourg.
pbi
Home & Garden Ltd., UK.
PGS
International N.V., Netherlands.
Pharma-Verlagsbuchhandlung
GmbH, Germany.
PO
JV LP, USA.
Productos
Quimicos Naturales S.A. de C.V., Mexico.
PT.
Bayer Indonesia, Indonesia.
PT.
Bayer MaterialScience Indonesia, Indonesia.
Radimetrics
Inc., Canada.
Radimetrics
UK Ltd., UK.
SB
Capital Corporation, USA.
SC
Bayer SRL, Romania.
Schering
Agrochemicals Holdings, UK.
Schering
Berlin Inc., USA.
Schering
do Brasil Quimica e Farmaceutica Ltda., Brazil.
Schering
Health Care Ltd., UK.
Schering
Holdings Ltd., UK.
Schering
Industrial Products, UK.
Schering
International Holding GmbH, Germany.
Schering-Kahlbaum
Gesellschaft mit beschränkter Haftung, Germany.
Secmer
SARL., France.
SIA
Bayer, Latvia.
Siebte
Bayer VV GmbH, Germany.
Soytech
Seeds Pesquisa em Soja Ltda., Brazil.
Stoneville
Pedigreed Seed Co., USA.
STWB
Inc., USA.
Sumika
Bayer Urethane Co. Ltd., Japan.
TecArena+GmbH,
Germany.
TECTRION
GmbH, Germany.
Texas
Brine Co. LLC, USA.
The
SDI Divestiture Corporation, US.
TOO
Bayer KAZ, Kazakhstan.
TravelBoard
GmbH, Germany.
U
I M Agrochemicals (Aust) Pty Ltd., Australia.
UAB
Bayer, Lithuania.
Vierte
Bayer Real Estate VV GmbH & Co. KG, Germany.
Viterion
TeleHealthcare LLC, US.
Willow
Road Co., US/
Worldwide
Soy Technologies LLC, USA.
ZAO
Bayer, Russia.
Zweite
Bayer Real Estate VV GmbH & Co. KG, Germany.
Zweite
K-W-A Beteiligungsgesellschaft mbH, Germany.
etc.
21927744
0636023
Managing Director: Mr. Johannes Matthias Dietsch
Nominal Share Capital: HK$100,000.00 (Divided into 100,000 shares of HK$1.00 each)
Issued Share Capital: HK$100,000.00
(As per registry
dated 11-02-2013)
|
Name |
|
No. of shares |
|
Bayer Far East Service Co. Ltd., Hong Kong. |
|
100,000 ====== |
(As per registry
dated 01-04-2013)
|
Name (Nationality) |
Address |
|
WAN Yim Ling |
Flat A, 10/F., Block 3, The Grand Panorama,
10 Robinson Road, Mid-Level, Hong Kong. |
|
Wolfgang Werner MIEBACH |
Kinderhausen 8, 51381 Leverkusen, Germany. |
(As per registry
dated 11-02-2013)
|
Name |
Address |
|
LEE Yuk Kwan |
Flat 1115, 11/F., Sheung Yat House, Upper Ngau Tau Kok
Estate, Kwun Tong, Kowloon, Hong Kong. |
The subject was incorporated on 11th February, 1998 as a private limited liability company under the Hong Kong Companies Ordinance.
Originally the subject was registered under the name of King Lion Corporation Ltd., name changed to Sybron Chemicals (Hong Kong) Ltd. on 31st July, 1998; changed to Bayer Polymers Co. Ltd. on 26th September, 2001; and further to the present style on 1st September, 2004.
Formerly the subject was located at 77/F., The Center, 99 Queen’s Road Central, Hong Kong, moved to the present address with effect from 18th June, 2012.
Apart from these, neither material change nor amendment has been ever traced and noted.
Activities: Importer and Exporter.
Lines: All kinds of plastic raw materials.
Company Employees: 180. (Hong Kong) - Including associates
Group Employees:- (As at 30-09-2013)
· 113,300. (Whole Group)
14,400. (Bayer MaterialScience Subgroup)
Commodities Imported: Germany, other European countries, India, etc.
Markets: Worldwide.
Group Net
Turnover:-
|
FY |
Whole Group |
Bayer
MaterialScience Subgroup |
|
Year ended 31-12-2008 |
€32,918 million |
€ 9,738 million |
|
Year ended 31-12-2009 |
€31,168 million |
€ 7,520 million |
|
Year ended 31-12-2010 |
€35,088 million |
€10,154 million |
|
Year ended 31-12-2011 |
€36,528 million |
€10,832 million |
|
Year ended 31-12-2012 |
€39,760
million |
€11,503
million |
|
9 months ended 30-09-2013 |
€30,269 million |
€ 8,547 million |
Terms/Sales: L/C or as per contracted.
Terms/Buying: L/C, D/P, etc.
The Hong Kong General
Chamber of Commerce, Hong Kong.
[Membership No. HKB0043]
Nominal Share Capital: HK$100,000.00 (Divided into 100,000 shares of HK$1.00 each)
Issued Share Capital: HK$100,000.00
Group Net Income: €1,719 million (Year ended 31-12-2008)
€1,359 million (Year ended 31-12-2009)
€1,301 million (Year ended 31-12-2010)
€2,470 million (Year ended 31-12-2011)
€2,446 million (Year ended 31-12-2012)
€2,734 million (9 months ended 30-09-2013)
MaterialScience EBIT: €633 million (Year ended 31-12-2011)
€597 million (Year ended 31-12-2012)
€365 million (9 months ended 30-09-2013)
Profit or Loss: Business is profitable.
Condition: Keeping in an active condition.
Facilities: Making active use of general banking facilities.
Payment: Met trade commitments as contracted.
Commercial Morality: Good.
Banker: Deutsche Bank AG, Hong Kong Branch.
Standing: Very Good.
Bayer MaterialScience Ltd. is a wholly-owned subsidiary of Bayer Far East Service Co. Ltd. [Bayer FE], a Hong Kong-registered firm located at the subject’s operating address. In turn, Bayer FE is a subsidiary of Bayer MaterialScience AG [Bayer MaterialScience], Germany. The ultimate holding company of the subject is Bayer AG [Bayer], a world famous Germany-based firm which is the holding company of the Bayer Group.
The subject is trading in the products of the Group.
The Group is principally engaged in supplying plastics, basic and fine chemicals flavours, fragrances and aromatic chemicals, polyurethanes, synthetic rubbers and rubber chemicals, coating and colorants, specialty products, fibres, pharmaceuticals, diagnostics, consumer care, crop protection and animal-health products to the Chinese market and importing finished and semi-finished raw materials and other intermediates and native products from the People’s Republic of China.
Bayer is one of the largest diversified international health care and chemicals groups. Founded in 1863 and headquartered at Leverkusen, Germany, Bayer today has subsidiaries or agencies in almost every country in the world.
Bayer (China) Ltd., a wholly-owned holding company, was registered in Beijing in September 1994 and is responsible for Bayer’s investments in China.
Bayer has eleven joint ventures and one wholly-owned enterprise in China: Bayer Healthcare Co. Ltd., Rhein Chemie (Qingdao) Ltd., Bayer Wuxi Leather Chemical Co. Ltd., Bayer Shanghai Pigments Co. Ltd., Bayer Sichuan Animal Health Co. Ltd., H & R Cosfra Ltd., Bayer Guangyi Panel Co. Ltd., Bayer Jinling Polyurethane Co. Ltd., Bayer Zhongxi Agrochemcial Co. Ltd., Bayer Zhongxi Consumer Care Co. Ltd., and Shanghai Fortune Long March - Trace Medical Science Co. Ltd.
Currently, the
subject is trading in the following products and offering clients with the
following services:-
|
Product/Service |
Product/Service
Remarks |
|
Pharmaceutical and
Medicine |
|
|
Veterinary
Medicine |
From Germany (Importer) From Germany (Exporter) |
|
Pharmaceutical
Preparation |
Include veterinary from Germany (Importer) Include veterinary from Germany (Exporter) |
|
Chemicals (including
Plastic Materials) |
|
|
Plastic
Materials (including Resins and Sheet) |
Include fluorescent plastic from Western Europe (Importer) Include fluorescent plastic from Western Europe (Exporter) |
|
Textile
Chemicals |
|
|
Dyeing,
Tanning and Colouring Materials |
Dyestuff from Germany (Importer) Dyestuff from Germany (Exporter) |
|
Industrial
Chemicals |
From Germany (Importer) From Germany (Exporter) |
|
Household
Chemicals |
|
|
Insecticide |
|
|
Agro-Chemicals |
|
|
Pesticide
For Agricultural Use |
|
The subject
carries the following brands:-
|
Brand Name |
Brand
Product/Service |
Brand Remarks |
|
Bayer (Brand Owner) |
Pharmaceutical Preparation |
|
|
Veterinary Medicine |
|
|
|
Agro-Chemicals |
|
|
|
Pesticide For Agricultural Use |
|
|
|
Insecticide |
Insecticides |
|
|
Industrial Chemicals |
|
|
|
Dyeing, Tanning and Colouring Materials |
|
|
|
Plastic Materials (including Resins and Sheet) |
|
|
|
Haarmann And Reimer (Official Agent) |
Industrial Chemicals |
SPICE |
Bayer MaterialScience is an independent, globally operating company within the Bayer Group. The name Bayer MaterialScience stands for the materials that the company develops and produces. It also stands for the know-how and expertise of its employees all over the world.
Bayer MaterialScience’s famous products are coating raw materials bearing the brandnames of “Bayhydrol®” and “Bayhydur®”. High-grade “Makrolon®”, “Makrofol®” and “Apec®” polycarbonates, together with the “Bayblend®” and “Makroblend®” polycarbonate blends, rank among Bayer MaterialScience’s best-sellers. These products are indispensable when it comes to the production of automotive components, data carriers such as CDs and DVDs, and a large number of other everyday items. The key product brands of Polyurethanes are “Desmodur®” and “Desmophen®”. Resins under the brand names “Desmopan®” and “Texin®” are used in technical films and textile coatings, belts, hoses, cables and profiles, in the automotive sector (interior, exterior, and chassis), in a multitude of applications in sports and leisure (e.g. ski and sport shoes and sport equipment), etc.
For the year ended 31st December, 2012, Bayer’s sales rose by 9.0% to a record €39.8 billion from €36.5 billion in FY 2011. Net income of the Group was €2.4 billion (2011: €2.5 billion), decreased by 1.0%.
With 2012 sales of €11.5 billion (2011: €10.8 billion), grew by 6.5%, Bayer Sales of the MaterialScience subgroup rose in 2012 by 3.0% to €11,503 million (reported: +6.2%). This growth was mainly the result of an overall increase in volumes, which were flat with the previous year in Europe but posted good gains in the other regions. In addition, the Group was able to slightly raise prices in all regions except Asia / Pacific.
The Bayer Group grew sales in the first nine months of 2013. EBITDA before special items improved slightly. The market-related weakness at MaterialScience was more than offset by the excellent development in its Life Science businesses.
Sales at MaterialScience were level with the corresponding period of previous year on an adjusted basis (Fx & portfolio adj. 0.0%; reported: –2.1%).
After non-controlling interest, the Bayer Group recorded net income of €2,734 million (9M 2012: €2,037 million).
MaterialScience spent €163 million on research and development in the first nine months of 2013, including €59 million in the third quarter. This investment went mainly to explore new areas of application and improve process technologies and products. In addition, MaterialScience invested €75 million in the first nine months of 2013 in joint development projects with customers, including €25 million in the third quarter.
In the Emerging Markets, MaterialScience had sales of €3,596 million in the first nine months of 2013 (9M 2012: €3,717 million), down just 1.3% (Fx adj.) from the prior-year period. Third-quarter sales in these countries declined by 2.5% (Fx adj.) to €1,219 million (Q3 2012: €1,306 million). The reason for the decline was an overall drop in sales in the Emerging Markets of Asia, with business in China holding steady year on year. Sales also developed negatively in Latin America despite gains in Brazil and Mexico. In Eastern Europe, on the other hand, it posted a slight increase. The Emerging Markets’ share of total MaterialScience sales was 42.1% in the first nine months of 2013 (9M 2012: 42.6%) and 42.1% in the third quarter of 2013 (Q3 2012: 43.7%).
On 30th September, 2013, the Bayer Group employed 113,300 people worldwide (31st December, 2012: 110,000). The number of employees thus showed an increase of 3,300 (+3.0%). HealthCare employed 56,600 people (31st December, 2012: 54,800). The number of employees at Crop-Science showed a seasonal increase to 21,800 (31st December, 2012: 20,800). There was a slight decline at MaterialScience to 14,400 employees (31st December, 2012: 14,500). The remaining 20,500 employees (31st December, 2012: 19,900 employees) mainly worked for the service companies.
The subject is fully supported by Bayer MaterialScience and ultimately by Bayer.
On the whole, in view of the parentage of the subject, consider it good for normal business engagements.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.61.53 |
|
|
1 |
Rs.101.08 |
|
Euro |
1 |
Rs.83.37 |
INFORMATION DETAILS
|
Report Prepared
by : |
DPT |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall
operation is considered normal. Capable to meet normal commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.